PATENT CLAIM ANALYSIS

Application Number: 16138360
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "361000"]

Abstract:
Provided are a pharmaceutical composition including: an alpha 2 (α2)-adrenoceptor agonist; a regulator of G-protein signaling (RGS) inhibitor, an endocytosis inhibitor, or a combination thereof; and a pharmaceutically acceptable salt, and a method of relieving pain of a subject, the method including administering the pharmaceutical composition to a subject.

Claim (Index 1):
A method of relieving chronic neuropathic pain of a subject, the method comprising:\n administering an alpha 2 (\u03b12)-adrenoceptor agonist, and a regulator of a G-protein signaling (RGS) inhibitor, an endocytosis inhibitor, or a combination thereof to the subject in need thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.58974
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10153154', '15269216', '14902556', '13625601', '12791506']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6866375175529832
- 35 USC 102 Novelty (BERT): 0.4912631656946451
- Combined Prediction Score: 0.6671000823671495
- Mean Citation Score: 173.17376199999995
- Max Citation Score: 186.37837
- Similarity Product: 132.5985211485201

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test